Back to Search
Start Over
Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial
- Source :
- American Journal of Kidney Diseases; December 2018, Vol. 72 Issue: 6 p798-810, 13p
- Publication Year :
- 2018
-
Abstract
- Epidemiologic and clinical studies have suggested that urate-lowering therapy may slow the progression of chronic kidney disease (CKD). However, definitive evidence is lacking.
Details
- Language :
- English
- ISSN :
- 02726386 and 15236838
- Volume :
- 72
- Issue :
- 6
- Database :
- Supplemental Index
- Journal :
- American Journal of Kidney Diseases
- Publication Type :
- Periodical
- Accession number :
- ejs46419512
- Full Text :
- https://doi.org/10.1053/j.ajkd.2018.06.028